| Sources | Names Used |
|---|---|
| GDSC1000 | HG-5-88-01 |
| PharmacoGx | HG-5-88-01 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CACNA2D1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | TALDO1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | SLAMF8 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | LAMTOR1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | HEATR9 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | CD164L2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | CHUK | GDSC1000 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | NR0B2 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | RHOU | GDSC1000 | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | KIAA0430 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
